Updated:
Denali Therapeutics Inc.
Denali Therapeutics Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001714899, and its reported...
Overview
Denali Therapeutics Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001714899, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2026-02-26, it reported annual revenue of USD 0; net income of USD -512,540,000; total assets of USD 1,144,854,000 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Denali Therapeutics Inc.
- Classification
- Public company
- Industry (SIC)
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters
- South San Francisco, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- Ticker
- Nasdaq: DNLI
- SEC CIK
- 0001714899
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2025USD | $0 | -$512.5M | $1.1B | $205.3M | -$412.6M | |
| FY2024USD | $0 | -$422.8M | $1.4B | $175.0M | -$347.7M | |
| FY2023USD | $330.5M | -$145.2M | $1.2B | $127.1M | -$358.0M | |
| FY2022USD | $108.5M | -$326.0M | $1.5B | $218.0M | -$244.7M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| DEF 14A | DEF 14A | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Denali Therapeutics Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.